Regulation & policy

Letter from congressman asks FDA to ramp up NDI enforcement

Letter from congressman asks FDA to ramp up NDI enforcement

By Hank Schultz

A letter from the office of Texas congressman Steve Stockman to the Food and Drug Administration urges the agency to better police the filing of New Dietary Ingredient notifications.  The letter says that there are some ingredients in the market whose...

Former FDA inspector offers insight into identity testing procedures

Former FDA inspector offers insight into identity testing procedures

By American Herbal Products Association

Tamika Cathey, a former FDA inspector and current independent regulatory consultant at EAS Consulting Group discusses identity verification regulations and methodologies. Cathey and 15 other industry experts will discuss botanical identity verification...

Mass fortification of iron, iodine still not the standard

Special Edition: Brain-boosting nutrients

Mass fortification of iron, iodine still not the standard

By Maggie Hennessy

As a growing body of evidence indicates that iron and iodine play a crucial role in the cognitive development of children, though the presence of multiple other influencers, along with differences in need at various life stages present challenges when...

EPA-only nutraceuticals ride pharma's coattails into marketplace

EPA-only nutraceuticals ride pharma's coattails into marketplace

By Hank Schultz

EPA-only ingredients and products are gaining traction in the supplements marketplace as more scientific evidence piles up for the ingredient as a standalone entity, independent of its source in oils that contain both EPA and DHA omega-3s.

Integrated data systems help cut cost of GMP compliance, providers say

Integrated data systems help cut cost of GMP compliance, providers say

By Hank Schultz

GMP compliance has been a steep hill to climb for the dietary supplement industry by some accounts. And the advent of the regulations, which took full force for all sectors of industry in June of 2010, wasn’t good news for the nation’s forests as manufacturers...

NDIs, GRAS & GMOs: CFSAN outlines priorities for 2013-14

NDIs, GRAS & GMOs: CFSAN outlines priorities for 2013-14

By Stephen DANIELLS

The Food and Drug Administration's (FDA) Center for Food Safety and Applied Nutrition (CFSAN) has outlined its priorities for 2013-14, with a 'surprising' number relevant to supplements, including NDIs, GRAS, and GMOs.

FDA warning letter disallows 14 Metagenics products as medical foods

FDA warning letter disallows 14 Metagenics products as medical foods

By Hank Schultz

Metagenics, a prominent California-based dietary supplement manufacturer that specializes in medical foods and supplements sold through the practitioner channel, has received a warning letter in which FDA says a number of its medical foods are mislabeled...

FDA clearly ramping up scrutiny of Indian pharma businesses

FDA clearly ramping up scrutiny of Indian pharma businesses

By RJ Whitehead

With two more warning letters sent by the US drug regulator to Indian companies for violation of acceptable manufacturing practices, America has brought to six the number of India-based drugmaking facilities against which it has taken action over the...

UPDATE: UK MHRA reinstates reformulated Dexaprine

UPDATE: UK reinstates reformulated Dexaprine after ban

The UK medicines regulator has reinstated fat burning supplement, Dexaprine, after learning the Californian manufacturer had developed a special formulation for the UK market with medicinal ingredients removed.

Challenge foreseen to FDA's exclusion of medical foods for diabetics

Challenge foreseen to FDA's exclusion of medical foods for diabetics

By Hank Schultz

FDA’s recently updated draft guidance on medical foods specifically excluded diabetes as a condition for which a medical food can be formulated and marketed. As there are a number of such foods on the market, this change has been greeted with some consternation...

Caffeine cards are on table following IOM meeting, observers say

Caffeine cards are on table following IOM meeting, observers say

By Hank Schultz

A recent workshop sponsored by the Institute of Medicine on caffeine and its effect in consumer products such as energy drinks was helpful in making clear the points of view of the various stakeholders, according to observers.  What was less clear was...

Follow us

Products

View more

Webinars